Del Poeta et al. reported increased levels of BCL2, BCL-XL and MCL1 expression in AML [23] and Aichberger et al. showed that MCL1 is a BCR-ABL target gene in CML [32]. Here, BCL2L1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.